Aamland A, Malterud K, El W (2012) Phenomena associated with sick leave among primary care patients with Medically Unexplained Physical Symptoms: a systematic review. Scand J Prim Health Care 30:147–155
PubMedPubMedCentralCrossRefAbbass A, Kisely S, Kroenke K (2009) Short-term psychodynamic psychotherapy for somatic disorders. Systematic review and metaanalysis of clinical trials. Psychother Psychosom 78:265–274
Alexander F (1951) Psychosomatische Medizin. Grundlagen und Anwendungsgebiete. De Gruyter, Berlin
Allen LA, Woolfolk RL (2010) Cognitive behavioral therapy for somatoform disorders. Psychiatr Clin North Am 33:579–593
PubMedCrossRefAllen LA, Woolfolk RL, Escobar JI et al (2006) Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med 166:1512–1518
PubMedCrossRefAnderson G, Berk M, Maes M (2014) Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome. Acta Psychiatr Scand 129:83–97
Arbeitskreis PISO (Hrsg) (2012) Somatoforme Störungen: Psychodynamisch-Interpersonelle Therapie (PISO). Hogrefe, Göttingen
Arconac O, Guze SB (1963) A family study of hysteria. N Engl J Med 268:239–242
CrossRefArnold IA, de Waal MW, Eekhof JA et al (2009) Medically unexplained physical symptoms in primary care: a controlled study on the effectiveness of cognitive-behavioral treatment by the family physician. Psychosomatics 50:515–524
PubMedCrossRefArnow BA (2004) Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization. J Clin Psychiatry 65 (Suppl 12):10–15
Barsky AJ (1992) Amplification, somatization, and the somatoform disorders. Psychosomatics 33:28–34
Barsky AJ, Orav EJ, Bates DW (2005) Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 62:903–910
PubMedCrossRefBarsky AJ, Orav EJ, Bates DW (2006) Distinctive patterns of medical care utilization in patients who somatize. Med Care 44:803–811
PubMedCrossRefBass C, Murphy M (1995) Review: somatoform and personality disorders: syndromal comorbidity and overlapping developmental pathways. J Psychosom Res 39:403–427
PubMedCrossRefBenjamin S, Eminson DM (1992) Abnormal illness behaviour: childhood experiences and long-term consequences. Int Rev Psychiatry 4:55–70
CrossRefBeutel ME, von Heymann F, Bleichner F et al (2014) Wie wirksam ist die psychosomatische Therapie bei somatoformen Störungen? Ergebnisse einer Multicenter-Studie. Z Psychosom Med Psychother 60:17–24
PubMedBion WR (1959) Attacks on thinking. Int J Psychoanal 40:308–315
Bohman M, Cloninger CR, Knorring von AL et al (1984) An adoption study of somatoform disorders: III. Cross-fostering analysis and genetic relationship to alcoholism and criminality. Arch Gen Psychiatry 41:872–878
Bonanno GA, Singer JL (1990) Repressive personality style: theoretical and methodological implications for health and pathology. In: Singer JL (Hrsg) Repression and dissociation: implications for personality theory, psychopathology, and health. University of Chicago Press, Chicago, S 435–470
Briquet P (1859) Traite de l’ hysterie. Bailliere et Fils, Paris
Brosschot JF, Pieper S, Thayer JF (2005) Expanding stress theory: prolonged activation and perseverative cognition. Psychoneuroendocrinology 30:1043–1049
PubMedCrossRefBrown RJ (2004) Psychological mechanisms of medically unexplained symptoms. An integrative conceptual model. Psychol Bull 130:793–812
Brown FW, Golding JM, Smith GR (1990) Psychiatric comorbidity in primary care somatization disorder. Psychosom Med 52:445–451
PubMedCrossRefBrown RJ, Schrag A, Trimble MR (2005) Dissociation, childhood interpersonal trauma, and family functioning in patients with somatization disorder. Am J Psychiatry 162:899–905
PubMedCrossRefBrowning M, Fletcher P, Sharpe M (2011) Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review. Psychosom Med 73:173–184
PubMedPubMedCentralCrossRefByrne D (1961) The repression-sensitization scale: rationale, reliability and validity. J Pers 29:334–349
PubMedCrossRefChernyak N, Sattel H, Scheer M et al (2014) Economic evaluation of brief psychodynamic interpersonal therapy in patients with multisomatoform disorder. PLoS One 9, e83894
PubMedPubMedCentralCrossRefCloninger CR, Sigvardsson S, Knorring AL von et al (1984) An adoption study of somatoform disorders, II: identification of two discrete somatoform disorders. Arch Gen Psychiatry 41:863–871
Cloninger CR, Martin RL, Guze SB, Clayton PJ (1986) A prospective follow-up and family study of somatization in men and women. Am J Psychiatry 143:873–878
PubMedCrossRefCoryell W (1981) Diagnosis-specific mortality. Arch Gen Psychiatry 38:939–942
PubMedCrossRefCraig TKJ, Boardman AP, Mills K et al (1993) The South London somatization study I: longitudinal course and the influence of early life experiences. Br J Psychiatry 163:570–588
Craig TK, Bialas I, Hodson S, Cox AD (2004) Intergenerational transmission of somatisation behaviour: 2. Observations of joint attention and bids for attention. Psychol Med 34:195–198
CrossRefCreed F, Barsky A (2004) A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 56:391–408
Creed F, Barsky A, Leiknes KA (2011) Epidemiology: Prevalence, causes and consequences. In: Creed F, Henningsen P, Fink P (Hrsg) (2001) Medically unexplained symptoms, somatization and bodily distress. Developing better clinical services. Cambridge University Press, Cambridge, S 1–42
Croicu C, Chwastiak L, Katon W (2014) Approach to the patient with multiple somatic symptoms. Med Clin North Am 98:1079–1095
Dantzer R (2005) Somatization: a psychoneuroimmune perspective. Psychoneuroendocrinology 30:947–952
PubMedCrossRefde Greck M, Scheidt L, Bölter AF et al (2012) Altered brain activity during emotional empathy in somatoform disorder. Hum Brain Mapp 33:2666–2685
PubMedCrossRefde Greck M, Bölter AF, Lehmann L et al (2013) Changes in brain activity of somatoform disorder patients during emotional empathy after multimodal psychodynamic psychotherapy. Front Hum Neurosci 7:410
PubMedPubMedCentralCrossRefde Gucht V, Fischler B, Heiser W (2004) Personality and affect as determinants of medically unexplained symptoms in primary care, a follow-up study. J Psychosom Res 56:279–285
de Waal MWM, Arnold IA, Eekhof JAH, Van Hemert AM (2004) Somatoform disorders in general practice prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 184:470–476
PubMedCrossRefde Waal MWM, Arnold IA, Spinhoven P et al (2005) The reporting of specific physical symptoms for mental distress in general practice. J Psychosom Res 59:89–95
PubMedCrossRefde Waal MW, Arnold IA, Eekhof JA et al (2008) Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care. BMC Fam Pract 9:5
PubMedPubMedCentralCrossRefDickinson WP, Dickinson LM, DeGruy FV et al (2003a) The somatisation in primary care study: a tale of three diagnoses. Gen Hosp Psychiatry 25:1–7
PubMedCrossRefDickinson WP, Dickinson LM, deGruy FV et al (2003b) A randomized clinical trial of a care recommendation letter intervention for somatisation in primary care. Ann Fam Med 1:228–235
PubMedPubMedCentralCrossRefDimsdale JE, Dantzer R (2007) A biological substrate for somatoform disorders. Psychosom Med 69:63–74
Dokucu ME, Cloninger CR (2006) Somatization disorder and undifferentiated somatoform disorder. In: Gabbard GO (Hrsg) Gabbard’s treatments of psychiatric disorders, 4. Aufl. American Psychiatric Publishing, Washington, DC/London, S 585–594
Ejeby K, Savitskij R, Ost LG et al (2014) Symptom reduction due to psychosocial interventions in not accompanied by a reduction in sick leave: results from a randomized controlled trial in primary care. Scand J Prim Health Care 32:67–72
PubMedPubMedCentralCrossRefEscobar JI, Burham A, Karno M et al (1987a) Somatization in the community. Arch Gen Psychiatry 44:713–718
PubMedCrossRefEscobar JI, Golding JM, Hough RL et al (1987b) Somatization in the community: relationship to disability and use of services. Am J Public Health 77:837–840
PubMedPubMedCentralCrossRefEscobar JI, Gara M, Cohen Silver R et al (1998) Somatization disorder in primary care. Br J Psychiatry 173:262–266
Eser-Valeri D (2014) Psychopharmakotherapie somatoformer Störungen. Psychiatrie 11:189–196
Fayed N, Andres E, Rojas G et al (2012) Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: a controlled study. Acta Psychiatr Scand 126:115–125
PubMedCrossRefFenichel O (1945) The psychoanalytical theory of neurosis. Norton, New York
Fink P (1992a) Physical complaints and symptoms of somatizing patients. J Psychosom Res 36:125–136
Fink P (1992b) Surgery and medical treatment in persistent somatizing patients. J Psychosom Res 36:439–447
Fink P (1992c) The use of hospitalizations by persistent somatizing patients. Psychol Med 22:173–180
Fink P, Rosendal M (2008) Recent developments in the understanding and management of functional somatic symptoms in primary care. Curr Opin Psychiatry 21:182–188
Fink P, Schröder A (2010) One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res 68:415–426
Fink P, Rosendal M, Toft T (2002) Assessment and treatment of functional disorders in general practice: the extended reattribution and management model – an advanced educational program for nonpsychiatric doctors. Psychosomatics 43:93–131
PubMedCrossRefFink P, Hansen MS, Oxhoj ML (2004) The prevalence of somatoform disorders among internal medical inpatients. J Psychosom Res 56:413–418
Fink P, Hansen MS, Sondergaard L (2005) Somatoform disorders among first-time referrals to a neurology service. Psychosomatics 46:540–548
Fink P, Toft T, Hansen MS et al (2007) Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med 69:30–39
Fjorback LO, Arendt M, Ornbøl E et al (2013a) Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up. J Psychosom Res 74:31–40
PubMedCrossRefFjorback LO, Carstensen T, Arendt M et al (2013b) Mindfulness therapy for somatization disorder and functional somatic syndromes: analysis of economic consequences alongside a randomized trial. J Psychosom Res 74:41–48
PubMedCrossRefFlor-Henry P, Fromm-Auch D, Taper M, Schopflocher D (1981) A neuropsychological study of the stable syndrome of hysteria. Biol Psychiatry 16:601–626
PubMedFonagy P, Gergely G, Jurist E, Target M (2003) Affect regulation, mentalization and the development of the self. Other Press, New York
Frewen PA, Dozois DJA, Neufeld RWJ, Lanius RA (2012) Disturbances of emotional awareness and expression in posttraumatic stress disorder: meta-mood, emotion regulation, mindfulness, and interference of emotional expressiveness. Psychol Trauma Theory Res Pract Policy 4:152–161
CrossRefFries E, Hesse J, Hellhammer J, Hellhammer DH (2005) A new view on hypocortisolism. Psychoneuroendocrinology 30:1010–1016
Frostholm L, Fink P, Oernboel E et al (2007) Do illness perceptions predict health outcomes in primary care patients? A 2-year follow-up study. J Psychosom Res 62:129–138
PubMedCrossRefFrostholm L, Petrie KJ, Ornbøl E, Fink P (2014) Are illness perceptions related to future healthcare expenditure in patients with somatoform disorders? Psychol Med 44:2903–2911
PubMedCrossRefGara MA, Silver RC, Escobar JI et al (1998) A hierarchical classes analysis (HICLAS) of primary care patients with medically unexplained somatic symptoms. Psychiat Res 81:77–86
Garcia-Campayo J, Fayed N, Serrano-Blanco A, Roca M (2009) Brain dysfunction behind functional symptoms: neuroimaging and somatoform, conversive, and dissociative disorders. Curr Opin Psychiatry 22:224–231
Gask L, Dowrick C, Salmon P et al (2011) Reattribution reconsidered: narrative review and reflections on an educational intervention for medically unexplained symptoms in primary care settings. J Psychosom Res 71:325–334
PubMedCrossRefGergely G, Watson J (1996) The social feedback model of parental affect-mirroring. Int J Psychoanal 77:1181–1212
PubMedGershuny BS, Thayer JF (1999) Relations among psychological trauma, dissociative phenomena, and trauma-related distress: a review and integration. Clin Psychol Rev 19:631–657
PubMedCrossRefGolding JM, Smith GR, Kashner TM (1991) Does somatization occur in men? Clinical characteristics of women and men with multiple unexplained symptoms. Arch Gen Psychiatry 48:231–235
PubMedCrossRefGoodwin DW, Guze SB (1989) Psychiatric diagnosis, 4. Aufl. Oxford University Press, New York/Oxford
Grabe HJ, Meyer C, Hapke U et al (2003) Somatoforme Störungen in der Allgemeinbevölkerung. Nervenarzt 44:304–311
Gündel H (2005) Alexithymie als Dimension von Persönlichkeitsstörung – Psychodynamische und neurobiologische Aspekte. Persönlichkeitsstörungen – Theorie und Therapie PTT 9:90–98
Gureje O, Simon GE, Ustun TB, Goldberg DP (1997) Somatization in cross-cultural perspective: a World Health Organization study in primary care. Am J Psychiatry 154:989–995
Guthrie E, Creed F, Dawson D, Tomenson B (1991) A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 100:450–457
Guthrie E, Creed F, Dawson D, Tomenson B (1993) A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome. Br J Psychiatry 163:315–321
Guze SB (1993) Genetics of Briquet’s syndrome and somatization disorder. A review of family, adoption, and twin studies. Ann Clin Psychiatry 5:225–230
PubMedCrossRefHalligan PW, David AS (1999) Conversion hysteria: towards a cognitive neuropsychological account. Cogn Neuropsychiatry 3:161–163
CrossRefHansen HS, Rosendal M, Fink P, Risør MB (2012) The general practitoner’s consultation approaches to medically unexplained symptoms: a qualitative study. ISRN Fam Med 2013:541604
Hausteiner-Wiehle C, Henningsen P, Häuser W et al (2013) Umgang mit Patienten mit nicht-spezifischen, funktionellen und somatoformen Körperbeschwerden. S3-leitlinie mit Quellentexten, Praxismaterialien und Patientenleitlinie. Schattauer, Stuttgart
Heim C, Ehlert U, Hellhammer DH (2001) The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25:1–35
CrossRefHenningsen P, Löwe B (2006) Depression, pain, and somatoform disorders. Curr Opin Psychiatry 19:19–24
PubMedCrossRefHenningsen P, Zimmermann T, Sattel H (2003) Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 65:528–533
Henningsen P, Zipfel S, Herzog W (2007) Management of functional somatic syndromes. Invited review. Lancet 396:946–955
Hilderink PH, Collard R, Rosmalen JG, Oude Voshaar RC (2013) Prevalence of somatoform disorders and medically unexplained symptoms in old age populations in comparison with younger age groups: a systematic review. Ageing Res Rev 12(1):151–156
PubMedCrossRefHiller W, Fichter MM (2004) High utilizers of medical care. A crucial subgroup among somatizing patients. J Psychosom Res 56:437–443
PubMedCrossRefHiller W, Rief W, Brähler E (2006) Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 41:704–712
Hiller W, Cebulla M, Korn HJ et al (2010) Causal symptom attributions in somatoform disorder and chronic pain. J Psychosom Res 68:9–19
Hoedeman R, Blankenstein AH, van der Feltz-Cornelis CM et al (2010) Consultation letters for medically unexplained physical symptoms in primary care. Cochrane Database Syst Rev 12, CD006524
Hudziak J, Boffeli J, Todd J et al (1996) Clinical study of the relation of borderline personality disorder to Briquet’s syndrome (hysteria), somatization disorder, antisocial personality disorder, and substance abuse disorders. Am J Psychiatry 153:1598–1606
PubMedCrossRefHuibers MJ, Beursekens AJ, Bleijenberg G, van Schayck CP (2007) Psychosocial interventions by general practitioners. Cochrane Database Syst Rev 3, CD003494
Jackson JL, Kroenke K (2006) Managing somatization: medically unexplained should not mean medically ignored. J Gen Intern Med 21:797–799
PubMedPubMedCentralCrossRefJackson JL, Passamonti M (2005) The outcomes among patients presenting in primary care with a physical symptom at 5 years. J Gen Intern Med 20:1032–1037
PubMedPubMedCentralCrossRefJackson J, Fiddler M, Kapur N et al (2006a) Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. J Psychosom Res 60:357–363
Jackson JL, O’Malley PG, Kroenke K (2006b) Antidepressants and cognitive-behavioral therapy for somatic syndromes. CNS Spectr 11:212–222
Janet P (1889) L’automatisme psychologique. Alcan, Paris
Kapfhammer HP (2001) Somatisierung – somatoforme Störungen – Ätiopathogenetische Modelle. Fortschr Neurol Psychiat 69:58–77
PubMedCrossRefKapfhammer HP (2005a) Somatisierung als Korrelat komplexer posttraumatischer Persönlichkeitsveränderungen. Persönlichkeitsstörungen – Theorie und Therapie PTT 9:116–126
Kapfhammer HP (2005b) Geschlechtsdifferenzielle Perspektive auf somatoforme Störungen. Psychiatrie & Psychotherapie 1/2:21–32
Kapfhammer HP (2006) Somatic symptoms in depression. Dialogues Clin Neurosci 8:227–239
Kapfhammer HP (2008) Somatoforme Störungen: Konzept, Klinik, Ätiopathogenese und Therapie. Nervenarzt 79:99–117
Kapfhammer HP (2012) Psychopharmakotherapeutische Ansätze für Patienten mit somatoformen Störungen und funktionellen Körpersyndromen. Nervenarzt 83:1128–1141
Kapfhammer HP, Dobmeier P, Mayer C, Rothenhäusler HB (1998) Konversionssyndrome in der Neurologie – eine psychopathologische und psychodynamische Differenzierung in Konversionsstörung, Somatisierungsstörung und artifizielle Störung. Psychosom Psychother Med Psychol 48:463–474
Kashner TM, Rost K, Cohen B et al (1995) Enhancing the health of somatization disorder patients. Effectiveness of short-term group therapy. Psychosomatics 36:462–470
PubMedCrossRefKaton W, Sullivan M, Walker E (2001) Medical symptoms without identified pathology: relationship to psychatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med 134:917–925
PubMedCrossRefKhan AA, Khan A, Harezlak J, Tu W, Kroenke K (2003) Somatic symptoms in primary care: etiology and outcome. Psychosomatics 44:471–478
PubMedCrossRefKirmayer LJ, Looper KJ (2006) Abnormal illness behaviour: physiological, psychological and social dimensions of coping with distress. Curr Opin Psychiatry 19:54–60
PubMedCrossRefKirmayer LJ, Robbins JM (1991) Three forms of somatization in primary care: prevalence, cooccurrence, and sociodemographic characteristics. J Nerv Ment Dis 179:647–655
Kirmayer LJ, Robbins JM, Paris J (1994) Somatoform disorders: personality and the social matrix of somatic distress. J Abnorm Psychol 103:125–136
PubMedCrossRefKleinstäuber M, Wittöft M, Hiller W (2011) Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev 31:146–160
Kleinstäuber M, Witthöft M, Steffanowski A et al (2014) Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev 11:CD010628
Koch H, van Bokhoven MA, ter Riet G et al (2007) Demographic characteristics and quality of life of patients with medically unexplained complaints: a descriptive study in general practice. Qual Life Res 16:1483–1489
PubMedPubMedCentralCrossRefKoelen JA, Houtveen JH, Abbass A et al (2014) Effectiveness of psychotherapy for severe somatoform disorder: meta-analysis. Br J Psychiatry 204:12–19
PubMedCrossRefKoh KB, Kang JI, Lee JD, Lee YJ (2010) Shared neural activity in panic disorder and undifferentiated somatoform disorder compared with healthy controls. J Clin Psychiatry 7:1576–1581
CrossRefKoh KB, Sohn SH, Kang JI et al (2012) Relationship between neural activity and immunity in patients with undifferentiated somatoform disorder. Psychiatry Res 202:252–256
PubMedCrossRefKonnopka A, Schaefert R, Heinrich S et al (2012) Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom 8:265–275
CrossRefKroenke K (2007) Efficacy of treatment for somatoform disorders. Psychosom Med 69:143–164
Kroenke K, Spitzer RL, deGruy FV et al (1997) Multisomatoform disorder: an alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry 54:352–358
PubMedCrossRefKrystal H (1997) Desomatization and the consequences of infantile psychic trauma. Psa Inquiry 17:126–150
CrossRefLader M, Sartorius N (1968) Anxiety in patients with hysterical conversion symptoms. J Neurol Neurosurg Psychiatry 31:490–495
PubMedPubMedCentralCrossRefLadwig KH, Marten-Mittag B, Erazo N, Gündel H (2001) Identifying somatization disorder in a population-based health examination survey. Psychosomatics 42:511–578
PubMedCrossRefLarisch A, Schweickhardt A, Wirsching M, Fritzsche K (2004) Psychosocial interventions for somatizing patients by the general practitioner: a randomized controlled trial. J Psychosom Res 57:507–514
PubMedCrossRefLazarus RS, Folkman S (1987) Transactional theory and research on emotions and coping. Eur J Personal 1:141–169
CrossRefLemche E, Giampietro VP, Brammer MJ et al (2013) Somatization severity associated with postero-medial complex structures. Sci Rep 3:1032
PubMedPubMedCentralCrossRefLidbeck J (2003) Group therapy for somatization disorders in primary care: maintenance of treatment goals of short cognitive-behavioural treatment one-and-a-half-year follow up. Acta Psychiatr Scand 197:449–456
CrossRefLiebherz S, Rabung S (2013) Wirksamkeit psychotherapeutischer Krankenhausbehandlung im deutschsprachigen Raum: Eine Meta-Analyse. Psychother Psychosom Med Psychol 63:355–364
PubMedCrossRefLipowski ZJ (1990) Somatization and depression. Psychosomatics 31:13–21
PubMedCrossRefLiskow B, Othmer E, Penick E et al (1986) Is Briquet’s syndrome a heterogeneous disorder? Am J Psychiatry 143:626–629
PubMedCrossRefLooper KJ, Kirmayer LJ (2002) Behavioral medicine approaches to somatoform disorders. J Consult Clin Psychol 70:810–827
Lumley MA, Stettner L, Wehmer F (1996) How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res 41:505–518
PubMedCrossRefMaes M, Twisk FN, Ringel K (2012) Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosom 8:286–295
Mai F (2004) Somatization disorder: a practical review. Can J Psychiatry 49:652–662
PubMedMai FM, Merskey H (1980) Briquet’s Treatise on Hysteria. A synopsis and commentary. Arch Gen Psychiatry 37:1401–1405
PubMedCrossRefMaier W (1998) Angst- und Somatisierungsstörungen. Fortschr Neurol Psychiat 66(Sonderheft 1):53–58
Manu P (2004) The psychopathology of functional somatic syndromes. Neurobiology and illness behaviour in chronic fatigue syndrome, fibromyalgia, Gulf War syndrome, irritable bowel syndrome, and premenstrual dysphoria. Haworth Medical Press, New York/London
Martin A, Härter M, Henningsen P, Hiller W, Kröner-Herwig B, Rief W (2013) Evidenzbasierte Leitlinie zur Psychotherapie somatoformer Störungen und assoziierter Syndrome. Hogrefe, Göttingen
McDougall J (1989) Theater of the body. WW Norton, New York/London
McFarlane AC, Ellis N, Barton C et al (2008) The conundrum of medically unexplained syndromes: questions to be answered. Psychosomatics 49:369–377
Meares R, Horvath T (1972) Acute and chronic hysteria. Br J Psychiatry 121:653–657
PubMedCrossRefMorriss RD, Gask L (2002) Treatment of patients with somatized mental disorder: effects of reattribution training on outcomes under the direct control of the family doctor. Psychosomatics 43:394–399
PubMedCrossRefMullins LL, Olson RA (1990) Familial factors in the etiology, maintenance, and treatment of somatoform disorders in children. Fam Syst Med 8:159–175
CrossRefNakao M, Yano E (2006) Somatic symptoms for predicting depression: one-year follow-up study in annual health examinations. Psychiatry Clin Neurosci 60:219–225
PubMedCrossRefNater UM, Gaab J, Rief W, Ehlert U (2006) Recent trends in behavioural medicine. Curr Opin Psychiatry 19:180–183
PubMedCrossRefNemiah JC, Sifneos PE (1970) Psychosomatic illness: a problem of communication. Psychoanal Q 44:81–106
Olde Hartman TC, Borghuis MS, Lucassen LBJ et al (2009) Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res 66:363–377
Paykel ES, Ramana R, Cooper Z et al (1995) Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25:1171–1180
PubMedCrossRefPennebaker JW, Watson D (1991) The psychology of somatic symptoms. In: Kirmayer LJ, Robins JM (Hrsg) Current concepts of somatization: research and clinical perspectives. American Psychiatric Press, Washington, DC, S 21–35
Pennebaker JW, Czaijka JA, Cropanzano R et al (1990) Levels of thinking. Person Soc Psychol Bull 16:743–757
CrossRefPerez DL, Barsky AJ, Vago DR et al (2015) A neural circuit framework for somatosensory amplification in somatoform disorders. J Neuropsychiatry Clin Neurosci 27:e40–e50
Peveler R, Kilkenny L, Kinmonth AL (1997) Medically unexplained physical symptoms in primary care: a comparison of self-report screening questionnaire and clinical opinion. J Psychosom Res 42:245–252
PubMedCrossRefRask MT, Rosendal M, Fenger-Grøn M et al (2015) Sick leave and work disability in primary care patients with recent-onset multiple medically unexplained symptoms and persistent somatoform disorders: a 10-year follow-up of the FIP study. Gen Hosp Psychiatry 37:53–59
PubMedCrossRefRiebel K, Egloff B, Witthöft M (2013) The implicit health-related self-concept in somatoform disorders. J Behav Ther Exp Psychiatry 44:335–342
PubMedCrossRefRief W, Auer C (2001) Is somatisation a habituation disorder? Physiological reactivity in somatization syndrome. Psychiatry Res 101:63–74
PubMedCrossRefRief W, Barsky AJ (2005) Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 30:996–1002
Rief W, Broadbent E (2007) Explaining medically unexplained symptom-models and mechanism. Clin Psychol Rev 27:821–841
Rief W, Rojas G (2007) Stability of somatoform symptoms – implications for classification. Psychosom Med 69:864–869
Rief W, Schaefer S, Hiller W, Fichter MM (1992) Lifetime diagnoses in patients with somatoform disorders: which came first? Eur Arch Psychiatry Clin Neurosci 241:236–240
PubMedCrossRefRief W, Hiller W, Geissner E, Fichter MM (1995) A two-year follow-up study of patients with somatoform disorders. Psychosomatics 36:376–386
PubMedCrossRefRief W, Shaw R, Fichter MM (1998b) Elevated levels of psychophysiological arousal and cortisol in patients with somatization syndrome. Psychosom Med 60:198–203
Rief W, Martin A, Klaiberg A, Brähler E (2005) Specific effects of depression, panic, and somatic symptoms on illness behavior. Psychosom Med 67:596–601
PubMedCrossRefRief W, Martin A, Rauh E et al (2006a) Evaluation of general practitioners’ training: how to manage patients with unexplained physical symptoms. Psychosomatics 47:304–311
Rief W, Heitmüller AM, Reisberg K, Ruddel H (2006b) Why reassurance fails in patients with unexplained symptoms: an experimental investigation of remembered probabilities. PloS Med 3:e269
Rodin GM (1991) Somatization: a perspective from self psychology. J Am Acad Psychoanal 19:367–384
PubMedRoloefs K, Spinhoven P (2007) Trauma and medically unexplained symptoms. Towards an integration of cognitive and neuro-biological accounts. Clin Psychol Rev 27:798–820
CrossRefRosendal M, Blankenstein AH, Morriss R et al (2013) Enhanced care by generalists for functional somatic symptoms and disorders in primary care. Cochrane Database Syst Rev 10, CD008142
Rost KM, Akins RN, Brown FW, Smith GR (1992) The comorbidity of DSM-III-R personality disorders in somatization disorder. Gen Hosp Psychiatry 14:322–326
PubMedCrossRefRost KM, Kashner MT, Smith GR (1994) Effectiveness of psychiatric intervention with somatization disorder patients: Improved outcomes at reduced costs. Gen Hosp Psychiatry 16:381–387
PubMedCrossRefRusso J, Katon W, Sullivan M et al (1994) Severity of somatization and its relationship to psychiatric disorders and personality. Psychosomatics 35:546–556
Sattel H, Lahmann C, Gündel H et al (2012) Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. Br J Psychiatry 200:60–67
Schaefert R, Kaufmann C, Wild B et al (2013) Specific collaborative group intervention for patients with medically unexplained symptoms in general practice: a cluster randomized controlled trial. Psychother Psychosom 82:106–119
Schoepf D, Heun R, Weiffenbach O et al (2003) 4-Wochen-Prävalenz somatoformer Störungen und assoziierte psychosoziale Beeinträchtigung. Nervenarzt 74:245–251
Schröder A, Rehfeld E, Ornbøl E et al (2012) Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial. Br J Psychiatry 200:499–507
PubMedCrossRefSchur M (1955) Some comments on the metapsychology of somatization. Psychoanal Study Child 10:119–164
Shapiro D (1965) Neurotic styles. Basic Books, New York
Sharma MP, Manjula M (2013) Behavioural and psychological management of somatic symptom disorders: an overview. Int Rev Psychiatry 25:116–124
PubMedCrossRefSharpe M, Bass C (1992) Pathophysiological mechanisms in somatization. Int Rev Psychiatry 4:81–97
CrossRefShorter E, Abbey S, Gillies LA et al (1992) Inpatient treatment of persistent somatization. Psychosomatics 33:295–301
PubMedCrossRefSimon GE, Gureje O (1999) Stability of somatization disorder and somatization symptoms among primary care patients. Arch Gen Psychiatry 56:90–95
PubMedCrossRefSimon AE, Borgwardt S, Lang UE, Roth B (2014) Cenestopathy in adolescence: an appraisal of diagnostic overlaps along the anxiety-hypochondriasis-psychosis spectrum. Compr Psychiatry 55:1122–1129
Smith GR, Monson RA, Ray DC (1986a) Patients with multiple unexplained symptoms. Arch Int Med 146:69–72
CrossRefSmith GR, Monson RA, Ray DC (1986b) Psychiatric consultation in somatization disorder: a randomized controlled study. N Engl J Med 314:1407–1413
PubMedCrossRefSmith GR, Rost K, Kashner TM et al (1995) A trial of the effect of a standardized psychiatric consultation on the health outcomes and costs in somatizing patients. Arch Gen Psychiatry 52:238–243
PubMedCrossRefSmith RC, Gardiner JC, Lyles JS et al (2005) Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms. Psychosom Med 67:123–129
PubMedPubMedCentralCrossRefSmith RC, Lyles JS, Gardiner JC et al (2006) Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. J Gen Intern Med 21:671–677
PubMedPubMedCentralCrossRefSmits FT, Brouwer HJ, ter Riet G, van Weert HC (2009) Epidemiology of frequent attenders: a 3-year historic cohort study comparing attendance, morbidity and prescriptions of one-year and persistent frequent attenders. BMC Public Health 9:36
PubMedPubMedCentralCrossRefSomashekar B, Jainer A, Wuntakal B (2013) Psychopharmacotherapy of somatic symptoms disorders. Int Rev Psychiatry 25:107–115
Speckens AEM, van Hemert AM, Bolk JH et al (1995) The acceptability of psychological treatment in patients with medically unexplained physical symptoms. J Psychosom Res 39:855–863
PubMedCrossRefSpitzer C, Barnow S (2005) Somatisierung als eigenständige Dimension von Persönlichkeitsstörungen. Persönlichkeitsstörungen – Theorie und Therapie PTT 9:106–115
Stahl SM (2013) Stahl’s essential psychopharmacology. Neuroscientific basis and practical applications. Cambridge University Press, Cambridge
Stein DJ, Muller J (2008) Cognitive-affective neuroscience of somatization disorder and functional somatic syndromes: reconceptualising the triad of depression-anxiety-somatic symptoms. CNS Spectr 13:379–384
PubMedCrossRefStenager EN, Svendsen MA, Stenager E (2003) Disability retirement pension for patients with symptom diagnoses: a register study on the basis of data from the Social Appeal Board. Ugeskr Laeger 165:469–474
PubMedStern J, Murphy M, Bass C (1993) Personality disorders in patients with somatization disorder. A controlled study. Br J Psychiatry 163:785–789
PubMedCrossRefStonnington CM, Locke DE, Hsu CH, Ritenbaugh C, Lane RD (2013) Somatization is associated with deficits in affective theory of mind. J Psychosom Res 74:479–485
PubMedCrossRefStuart S, Noyes R (2006) Interpersonal psychotherapy for somatizing patients. Psychother Psychosom 75:209–219
Swartz M, Blazer D, George L et al (1986a) Somatization disorder in a community population. Am J Psychiatry 143:1403–1408
Swartz M, Landerman R, George L et al (1986b) Somatization disorder. In: Robbins LN, Regier D (Hrsg) Psychiatric disorders in America. Free Press, New York, S. 220–255
Taylor GJ (2003) Somatization and conversion: distinct or overlapping constructs. J Am Acad Psychoanal Dyn Psychiatry 31:487–508
PubMedCrossRefThayer JF, Brosschot JF (2005) Psychosomatics and psychopatholoy: looking up and down from the brain. Psychoneuroendocrinology 30:1050–1058
PubMedCrossRefToft T, Rosendal M, Ørnbøl E et al (2010) Training general practitioners in the treatment of functional somatic symptoms: effects on patient health in a cluster-randomised controlled trial (the Functional Illness in Primary Care study). Psychother Psychosom 79:227–237
PubMedCrossRefTomasson K, Kent D, Coryell W (1991) Somatization and conversion disorders: comorbidity and demographics at presentation. Acta Psychiatr Scand 84:288–293
PubMedCrossRefTomenson B, Essau C, Jacobi F et al (2013) Total somatic symptom score as a predictor of health outcome in somatic symptom disorders. Br J Psychiatry 203:373–380
PubMedCrossRefVan der Feltz-Cornelis CM, Van Oppen P et al (2006) Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. Psychother Psychosom 75:282–289
Van der Hart O, Nijenhuis E, Steel K, Brown D (2004) Trauma-related dissociation: conceptual clarity lost and found. Aust NZ J Psychiatry 38:906–914
CrossRefvan Dessel N, den Boeft M, van der Wouden JC et al (2014) Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev 11:CD011142
van Ravesteijn H, Grutter J, olde Hartmann T et al (2013) Mindfulness-based cognitive therapy for patients with medically unexplained symptoms: a cost-effectiveness study. J Psychosom Res 74:197–205
PubMedCrossRefVerhaak PF, Meijer SA, Visser AP, Wolters G (2006) Persistent presentation of medically unexplained symptoms in general practice. Fam Pract 23:414–420
PubMedCrossRefVögele C (1998) Die Interozeption körperlicher Empfindungen bei somatoform gestörten Patienten. In: Margraf J, Neumer S, Rief W (Hrsg) Somatoforme Störungen. Ätiologie, Diagnose und Therapie. Springer, Berlin/Heidelberg/New York, S 167–182
CrossRefVoigt K, Nagel A, Meyer B et al (2010) Towards positive diagnostic criteria: a systematic review of somatoform disorder diagnoses and suggestions for future classification. J Psychosom Res 68:403–414
Voigt K, Wollburg E, Weinmann N et al (2012) Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder – comparison with DSM-IV somatoform disorders and additional criteria for consideration. J Psychosom Res 73:345–350
PubMedCrossRefVoigt K, Wollburg E, Weinmann N et al (2013) Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder: prospective 1-year follow-up study. J Psychosom Res 75:358–361
PubMedCrossRefWaldinger RJ, Schulz MS, Barsky AJ, Ahern DK (2006) Mapping the road from childhood trauma to adult somatization: the role of attachment. Psychosom Med 68:129–135
PubMedCrossRefWalker LS, McLaughlin FJ, Greene JW (1988) Functional illness and family functioning: a comparison of healthy and somatizing adolescents. Fam Proc 27:317–325
CrossRefWaller E, Scheidt CE (2004) Somatoform disorders as disorders of affect regulation a study comparing the TAS-20 with non-self-report measures of alexithymia. J Psychosom Res 57:239–247
PubMedCrossRefWaller E, Scheidt CE (2006) Somatoform disorders as disorders of affect regulation: a development perspective. Int Rev Psychiatry 18:13–24
PubMedCrossRefWilhelmsen I (2005) Biological sensitisation and psychological amplification: Gateways to subjective health complaints and somatoform disorders. Psychoneuroendocrinology 30:990–995
Witthöft M, Hiller W (2010) Psychological approaches to origins and treatments of somatoform disorders. Annu Rev Clin Psychol 6:257–283
PubMedCrossRefWoerner PI, Guze SB (1968) A family and marital study of hysteria. Br J Psychiatry 114:161–168
PubMedCrossRefWollburg E, Voigt K, Braukhaus C et al (2013) Construct validity and descriptive validity of somatoform disorders in light of proposed changes for the DSM-5. J Psychosom Res 74:18–24
PubMedCrossRefYoshimasu K (2012) Substance-related disorders and somatic symptoms: how should clinicians understand the associations? Curr Drug Abuse Rev 5:291–303
PubMedCrossRefZoccolillo MS, Cloninger CR (1986) Somatization disorder: psychologic symptoms, social disability, and diagnosis. Compr Psychiatry 27:65–73
PubMedCrossRef